Moreover, two-sample MR studies conducted by UK scientists underscored the potential impact of sex steroid hormones on breast cancer risk, These studies pointed out that testosterone and bioavailable testosterone could elevate the risk of both overall and estrogen receptor-positive (ER-positive) breast cancer [39, 40]. This evidence concerns the gene ESR1 and breast carcinoma.